Search all trials

Find therapies in clinical trials near you – page 12

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Study of the safety and effects of gepotidacin in children aged 2 to 12 years with bacterial infections such as urinary tract infections

Not yet recruiting

InvestigationalNo placebo

Study of the safety and effects of gepotidacin in children aged 2 to 12 years with bacterial infections such as urinary tract infections

InvestigationalNo placebo

Poland

Participants:0–17 years

Contact Research Centre

Hidradenitis

Not yet recruiting

Investigational

A study to evaluate the effectiveness and safety of zasocitinib in patients with moderate to severe hidradenitis suppurativa

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Zasocitinib

Contact Research Centre

Congenital growth hormone deficiency

Not yet recruiting

Investigational

Study of the effects of Ibutamoren Mesilate in prepubertal children with growth hormone deficiency

Investigational

Poland

Participants:0–17 years
Substances:Ibutamoren Mesilate

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Registered drug

Study of zipalertinib plus chemotherapy versus placebo plus chemotherapy in patients with stage IB-IIIA non-small cell lung cancer with uncommon EGFR mutations after surgery

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Cardiac failure

Not yet recruiting

Investigational

Study on COR-1167 for Patients with Worsening Heart Failure

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Colitis ulcerative

Not yet recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of OD-07656 and Vedolizumab for Patients with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Vedolizumab

Contact Research Centre

Multiple sclerosis relapse

Not yet recruiting

Registered drugNo placebo

Study on Ofatumumab Levels in Breast Milk of Women with Relapsing Multiple Sclerosis

Registered drugNo placebo

Poland

Participants:18–64 years
Substances:Ofatumumab

Contact Research Centre

Pulmonary sarcoidosis

Not yet recruiting

Investigational

Study on the Effects of OATD-01 for Patients with Active Pulmonary Sarcoidosis

Investigational

Poland

Participants:18–64 years
Substances:5-(4-((2S,5S)-5-(4-Chlorobenzyl)-2-Methylmorpholino)Piperidin-1-Yl)-1H- 1,2,4-Triazol-3-Amine

Contact Research Centre

Acute myeloid leukaemia

Not yet recruiting

Registered drugNo placebo

Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using CPX-351, Gemtuzumab Ozogamicin, and a Drug Combination

Registered drugNo placebo

Poland

Participants:0–17 years · 18–64 years
Substances:Busulfan

Contact Research Centre

Renal cell carcinoma

Not yet recruiting

Registered drugNo placebo

Study comparing XL092 plus nivolumab versus sunitinib for patients with advanced or metastatic non-clear cell kidney cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Acute myeloid leukaemia+1

Not yet recruiting

Registered drugNo placebo

Study of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome

Registered drugNo placebo

Poland

Participants:0–17 years
Substances:Cytarabine

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Registered drug

Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

Registered drug

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

Find therapies in clinical trials near you – page 12

339 trials match your criteria

Study of the safety and effects of gepotidacin in children aged 2 to 12 years with bacterial infections such as urinary tract infections

Study of the safety and effects of gepotidacin in children aged 2 to 12 years with bacterial infections such as urinary tract infections

Hidradenitis

A study to evaluate the effectiveness and safety of zasocitinib in patients with moderate to severe hidradenitis suppurativa

Congenital growth hormone deficiency

Study of the effects of Ibutamoren Mesilate in prepubertal children with growth hormone deficiency

Non-small cell lung cancer

Study of zipalertinib plus chemotherapy versus placebo plus chemotherapy in patients with stage IB-IIIA non-small cell lung cancer with uncommon EGFR mutations after surgery

Cardiac failure

Study on COR-1167 for Patients with Worsening Heart Failure

Colitis ulcerative

Study on the Safety and Effectiveness of OD-07656 and Vedolizumab for Patients with Moderate to Severe Ulcerative Colitis

Multiple sclerosis relapse

Study on Ofatumumab Levels in Breast Milk of Women with Relapsing Multiple Sclerosis

Pulmonary sarcoidosis

Study on the Effects of OATD-01 for Patients with Active Pulmonary Sarcoidosis

Acute myeloid leukaemia

Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using CPX-351, Gemtuzumab Ozogamicin, and a Drug Combination

Renal cell carcinoma

Study comparing XL092 plus nivolumab versus sunitinib for patients with advanced or metastatic non-clear cell kidney cancer

Acute myeloid leukaemia+1

Study of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome

Systemic lupus erythematosus

Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.